The average yield for blue chip dividend stocks is typically around 3% to 4%, making Pfizer’s nearly 7% yield notable. Despite recent stock performance issues due to decreased demand for its COVID-19 vaccine and Paxlovid, Pfizer has consistently paid dividends for decades and raised its annual payout for 16 years. The company’s revenue has dropped about 40% from its 2022 peak of over $100 billion. The market may have overreacted to this decline in revenue.
